Guided Therapeutics Inc
OTC:GTHP

Watchlist Manager
Guided Therapeutics Inc Logo
Guided Therapeutics Inc
OTC:GTHP
Watchlist
Price: 0.19 USD
Market Cap: $18.3m

Guided Therapeutics Inc
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Guided Therapeutics Inc
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
Guided Therapeutics Inc
OTC:GTHP
Inventory
$448k
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
-9%
Boston Scientific Corp
NYSE:BSX
Inventory
$2.9B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
11%
Edwards Lifesciences Corp
NYSE:EW
Inventory
$1.1B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
13%
Stryker Corp
NYSE:SYK
Inventory
$5.3B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
12%
Abbott Laboratories
NYSE:ABT
Inventory
$6.5B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
9%
Intuitive Surgical Inc
NASDAQ:ISRG
Inventory
$1.8B
CAGR 3-Years
27%
CAGR 5-Years
25%
CAGR 10-Years
27%
No Stocks Found

Guided Therapeutics Inc
Glance View

Market Cap
18.3m USD
Industry
Health Care

Guided Therapeutics, Inc. engages in the development of medical devices. The company is headquartered in Norcross, Georgia. The firm is focused on selling and marketing of its LuViva advanced cervical scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. The firm focuses on two primary applications for LuViva as a cancer screening tool, and triage traditional screening. Screening is for cervical cancer represents the practice of diagnostic medicine. The firm is also focused on the extension of its cancer detection technology into other cancers, including esophageal.

GTHP Intrinsic Value
0.03 USD
Overvaluation 83%
Intrinsic Value
Price $0.19

See Also

What is Guided Therapeutics Inc's Inventory?
Inventory
448k USD

Based on the financial report for Dec 31, 2025, Guided Therapeutics Inc's Inventory amounts to 448k USD.

What is Guided Therapeutics Inc's Inventory growth rate?
Inventory CAGR 10Y
-9%

Over the last year, the Inventory growth was -29%. The average annual Inventory growth rates for Guided Therapeutics Inc have been -7% over the past three years , -6% over the past five years , and -9% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett